ACROBiosystems upgrades HEK293 licence solution for R&D compliance
Customers have authorisation to use HEK293 functional cell lines for research, discovery, and assay development.
Drug Development
BMS’ Sotyktu secures EC approval for psoriatic arthritis
Construction begins on Novartis’ RLT centre in Texas, US
Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn
Daiichi Sankyo and Waiv partner for ADC biomarkers
Halozyme and Oruka sign agreement for Hypercon technology
Citius raises $36.5m for Lymphir commercialisation
MSD concludes Terns acquisition to expand CML pipeline
